Stockreport
AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711 [Yahoo! Finance]
Last evolus, inc. earnings: 2/25 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations: us.evolis.com/investor-relations
biopharmaceutical company advancing ABP-450 (prabotulinumtoxinA) as a biosimilar to BOTOX ® (onabotulinumtoxinA) to achieve full-label U.S. market entry, today announced that, on April 2, 2026, in connection with the appointment of John Bencich as Chief Financial Officer, the Company's Compensation Committee of the Board of Directors (the “Compensation Committee”) approved the grant of inducement awards. The Compensation Committee approved the grant to Mr. Bencich of 754,717 restricted stock units (“RSUs”) under AEON's 2025 Employment Inducement Incentive Award Plan (the “Inducement Plan”), which provides for the granting of equity awards to new employees of the Company. The RSUs vest over four years, 25% on each annual anniversary of March 9, 2026, which was Mr. Bencich's employment start date. In addition, the Compensation Committee approved the grant to Mr. Bencich of 235,849 performance-based restricted stock units (“PSUs”) under the Inducement Plan. The PSUs will vest as follow
[Read more]
| IMPACT SNAPSHOT | EVENT TIME: | EOLS | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| LAST PRICE | ||
| VWAP | ||
|
High:
|
MAX UP |
High:
|
|
Low:
|
MAX DOWN |
Low:
|
|
%
|
POST NEWS RANGE |
%
|
|
|
PRICE CHANGE |
|
|
|
PRICE CHANGE PERCENTAGE |
|
|
|
S&P 500 (SPX) |
|
|
%
|
VOLUME RATIO |
%
|
| VOLUME (SHARES) | ||
| TICKS | ||
|
|
AVG SHARES PER TRADE |
|
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Be the first to know
Opt in for alerts from News Quantifed
Opt-in for
EOLS alerts
EOLS alerts
from News Quantified
Movers & Shakers
The biggest gainers and losers and WHY it moved
EOLS alerts
High impacting Evolus, Inc. news events
Weekly update
A roundup of the hottest topics
EOLS
NEWS
NEWS
- Evolus Targets Double-Digit Growth, Full-Year Profitability at Needham Healthcare Conference [Yahoo! Finance][Yahoo! Finance]
- Evolus to Report First Quarter Financial Results on May 4, 2026[Business Wire]
- Telix Appoints David Gill as Non-Executive Director [Yahoo! Finance][Yahoo! Finance]
- Evolus to Participate in the Needham 25th Annual Virtual Healthcare Conference[Business Wire]
- Aviva Aesthetics Partners with Nationally Recognized Injector Jordan White and Urban Medical, Expanding into Arizona and Virginia[PR Web]
- More
EOLS
SEC Filings
SEC Filings
- 3/26/26 - Form SCHEDULE
- 3/20/26 - Form 4
- 3/20/26 - Form 4
- EOLS's page on the SEC website
- More